Traws Pharma Inc (TRAW) — Cash Flow-to-Debt Ratio
Traws Pharma Inc (TRAW) has a Cash Flow-to-Debt Ratio of -0.51x as of September 2025, meaning its operating cash flow of $-4.01 Million could theoretically repay -1% of its total liabilities ($7.90 Million) in one year. See cash generation quality of Traws Pharma Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Traws Pharma Inc Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Traws Pharma Inc across 14 annual periods. Also explore TRAW year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Traws Pharma Inc (2011–2024)
Year-by-year debt coverage analysis for Traws Pharma Inc. For market capitalisation and broader financial context, see Traws Pharma Inc (TRAW) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.53x | $-29.79 Million | $56.59 Million | ▲ +64.7% |
| 2023 | -1.49x | $-17.93 Million | $12.01 Million | ▼ -1.4% |
| 2022 | -1.47x | $-16.29 Million | $11.06 Million | ▲ +29.3% |
| 2021 | -2.08x | $-19.49 Million | $9.36 Million | ▼ -24.6% |
| 2020 | -1.67x | $-23.07 Million | $13.81 Million | ▲ +3.0% |
| 2019 | -1.72x | $-20.83 Million | $12.10 Million | ▲ +4.9% |
| 2018 | -1.81x | $-22.70 Million | $12.54 Million | ▼ -20.4% |
| 2017 | -1.50x | $-23.82 Million | $15.84 Million | ▼ -72.2% |
| 2016 | -0.87x | $-15.81 Million | $18.11 Million | ▲ +64.8% |
| 2015 | -2.48x | $-31.31 Million | $12.61 Million | ▼ -2.2% |
| 2014 | -2.43x | $-57.65 Million | $23.71 Million | ▲ +4.0% |
| 2013 | -2.53x | $-61.38 Million | $24.25 Million | ▼ -37632.1% |
| 2012 | 0.01x | $1.63 Million | $242.16 Million | ▲ +106.8% |
| 2011 | -0.10x | $-14.17 Million | $142.88 Million | — |